Although the development of therapies and tools for the improved management of heart
failure (HF) continues apace, day‐to‐day management in clinical practice is often far from …

Sodium–glucose transport inhibitors (SGLT2i) are effective in heart failure (HF) with ejection
fraction (EF)< 40%(referred to as HF with reduced EF–HFrEF) and left ventricular EF …

Objective: To estimate the prevalence, incidence, and describe the characteristics and
management of patients with heart failure with preserved (HFpEF), mildly reduced …

Aims Heart failure outcomes remain poor despite advances in therapy. The European
Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF …

A substantial proportion of patients with heart failure (HF) receive suboptimal guideline-
recommended therapy. We aimed to identify the factors leading to suboptimal drug …

Guideline‐directed medical therapy (GDMT) in patients with heart failure and reduced
ejection fraction (HFrEF) reduces morbidity and mortality, but its implementation is often poor …

In dilated cardiomyopathy (DCM), where the heart muscle becomes stretched and thin, heart
failure (HF) occurs, and the cardiomyocytes suffer from an energetic inefficiency caused by …

Major international practice guidelines recommend the use of a combination of 4 medication
classes in the treatment of patients with heart failure with reduced ejection fraction (HFrEF) …

Background The crosstalk of purine biosynthesis and metabolism exists to balance the cell
energy production, proliferation, survival and cytoplasmic environment stability, but …

In this context, a post hoc analysis of this web-based international survey limited to the
population of HF specialists versus non-specialists (excluding cardiologists in training and …